Warnings and precautions
Consult your doctor or pharmacist before starting to take Zyloric
Severe skin reactions that can be life-threatening (Stevens-Johnson syndrome and toxic epidermal necrolysis) with the use of Zyloric initially appear as red, circular spots or patches, often with a central blister.
The period of highest risk of developing severe skin reactions is during the first weeks of treatment.
If you develop Stevens-Johnson syndrome or toxic epidermal necrolysis with the use of Zyloric, you should not use this medication again at any time.
If you are unsure, consult your doctor.
You should stop your treatment and contact your doctor as soon as possible if, while you are taking Zyloric, you experience any of the following symptoms:
It is possible that an acute attack of gout may precipitate at the beginning of treatment with Zyloric. Your doctor will recommend the use of certain medications to prevent it. If an attack of gout occurs, it is not necessary to stop treatment with Zyloric as long as an appropriate anti-inflammatory medication is used concurrently.
Children
The use in children is rarely indicated, except for some types of cancer (especially leukemia) and certain enzymatic disorders such as Lesch-Nyhan syndrome.
Other medications and Zyloric 100 mg tablets
Inform your doctor or pharmacist if you are using or have recently used other medications, including those purchased without a prescription.
Your doctor will monitor your hematological controls frequently.
Inhibitors of the ECA (e.g., captopril) or diuretics (used to treat high blood pressure). The risk of developing skin reactions may increase, especially in patients with chronic limitations of renal function.
Administration of 6-mercaptopurine or azathioprine with allopurinol should be avoided. When 6-mercaptopurine or azathioprine are administered with Zyloric, the dose of 6-mercaptopurine or azathioprine should be reduced because its activity will be prolonged. This may increase the risk of severe blood disorders. In this case, your doctor will closely monitor your hemogram during treatment.
Seek medical attention immediately if you notice any unexplained bruising, bleeding, fever, or sore throat.
If you take aluminum hydroxide concomitantly, allopurinol may be attenuated, so you should leave a gap of at least 3 hours between taking both medications.
Administration of allopurinol in combination with cytostatics (e.g., cyclophosphamide, doxorubicin, bleomycin, procarbazine, alkylating agents) results in more frequent hematological disorders than when these active principles are administered alone.
Therefore, periodic hematological controls should be performed.
Pregnancy, lactation, and fertility
Zyloric is not recommended if you are pregnant.
Allopurinol passes into breast milk. Zyloric is not recommended during lactation.
Consult your doctor or pharmacist before using any medication.
Due to its side effects (drowsiness, dizziness, and coordination impairment), Zyloric may impair your ability to drive vehicles.
Do not drive, do not operate tools or machinery until you are reasonably sure that the medication does not limit your abilities.
Zyloric 100 mg tablets contain lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medication.
Oral use only. Swallow the tablet whole with a little water. It is usually taken once a day, generally after a meal.
Generally, your doctor will start treatment with allopurinol at a low dose (e.g., 100 mg/day), to reduce the risk of possible adverse effects. Your dose will be increased if necessary..
Dosage recommendation is:
Adults:
The initial recommended dose is 100 to 300 mg. The dose may be increased up to 900 mg per day, depending on your case. In this case, and if stomach discomfort appears, it is recommended to divide the dose into several daily doses and take them with food.
Children under 15 years:
The recommended dose of this medication in children is 100 to 400 mg per day.
Advanced age:
Your doctor will recommend the lowest possible dose of Zyloric to reduce uric acid levels and control your symptoms.
Use in patients with liver or kidney dysfunction:
If you have liver or kidney problems, your doctor will prescribe the lowest possible dose of Zyloric that can reduce uric acid levels and control your symptoms. In case of kidney insufficiency, your doctor may advise you to take less than 100 mg per day or to take single doses of 100 mg at intervals greater than one day. If you are on dialysis 2 or 3 times a week, your doctor may prescribe a dose of 300-400 mg immediately after each dialysis session.
If you take more Zyloric 100 mg tablets than you should:
In this case, consult the Toxicological Information Service. Phone 91 562 04 20 or visit your doctor.
In case of accidental ingestion of a large amount of medication, go to your doctor immediately or to the nearest hospital emergency room. Bring this leaflet with you.
If you forget to take Zyloric 100 mg tablets:
If you forget to take a dose, take the next dose as soon as you remember. Then, continue taking it as you normally do. Do not take a double dose to compensate for the missed doses.
If you forget several doses, it is best to contact your doctor to decide what to do from then on.
If you interrupt treatment with Zyloric 100 mg tablets:
Your doctor will indicate the duration of treatment with Zyloric. Do not stop treatment before, even if you feel better.
If you have any other doubts about the use of this product, ask your doctor or pharmacist.
Like all medicines, Zyloric may cause some side effects, although not everyone will experience them.
The likelihood of these occurring is higher when there are kidney and/or liver abnormalities.
The frequency of side effects is classified as:
Very common(affects less than 1 in 10 patients)
Common(affects less than 1 in 100 patients)
Uncommon(affects less than 1 in 1,000 patients)
Rare(affects less than 1 in 10,000 patients)
Very rare(affects less than 1 in 10,000 patients)
Frequency not known(cannot be estimated from available data)
Infections and infestations
Very rareFolliculitis.
Blood and lymphatic system disorders
Very rareDecreased white blood cell count: leucopenia (increases the risk of infections), red blood cell count: anemia (may cause fatigue, tiredness), platelet count (cells involved in blood clotting, with the appearance of bruises or bleeding, more easily than usual).
In some cases, allopurinol tablets may cause effects on the blood that manifest with the appearance of more frequent bruises, sore throat, or other signs of infection. These effects usually occur in people with kidney or liver problems. Inform your doctor as soon as possible if you have any of these symptoms.
Immune system disorders
UncommonReactions of hypersensitivity (allergy: possible appearance of skin rash, skin peeling, blisters, or sores on the lips or in the mouth).
RareSevere hypersensitivity reactions, associated with exfoliation, fever, joint pain, or painful swelling of the groin, armpits, or neck, jaundice (yellowing of the skin and eyes), and other skin and subcutaneous tissue alterations (see below).
Very rareLymphadenopathy angioimmunoblastic (occurs with weight loss, fever, inflammation in the lymph nodes of the armpits, neck, and groin), potentially fatal allergic reaction.
Very rarely, seizures, wheezing (popping sounds), palpitations, chest tightness, or loss of consciousness may occur.
Metabolic and nutritional disorders
Very rareDiabetes mellitus (elevated blood glucose levels), increased levels of lipids in the blood, increased uric acid levels in the blood.
Mental disorders
Very rareDepression.
Nervous system disorders
Very rareWeakness, numbness, or loss of consciousness, paralysis, motor coordination disorder (lack of coordination of movements), alteration of normal sensitivity (neuropathy), paresthesia (tingling sensation), drowsiness, headache, alteration in taste.
Frequency notknownAsymptomatic increases in liver function tests: meningitis aséptica (inflammation of the membranes surrounding the brain and spinal cord): symptoms include neck stiffness, headache, nausea, fever, or loss of consciousness. If you experience any of these symptoms, seek urgent medical attention..
Eye disorders
Very rareCataracts, visual disturbances.
Ear and labyrinth disorders
Very rareVestibular disorders.
Cardiac disorders
Very rareChest pain or bradycardia (slow heart rate).
Vascular disorders
Very rareHigh blood pressure (hypertension).
Gastrointestinal disorders
UncommonNausea, vomiting.
Very rareBlood in vomit, excessive fat in stool, mouth infections, changes in bowel habits.
Hepatobiliary disorders
UncommonAsymptomatic increases in liver function tests.
RareHepatitis.
Skin and subcutaneous tissue disorders
CommonSkin rash.
Very rareUrticaria, drug-induced skin eruptions that may threaten the patient's life (Stevens-Johnson syndrome and toxic epidermal necrolysis) (see section 2. Before taking Zyloric 100 mg tablets), hair loss or discoloration, severe allergic reaction that causes facial or throat swelling.
Frequency not knownLichenoid skin eruption (red-violet skin rash with itching or white-grayish lines on mucous membranes)
Renal and urinary disorders
Very rareBlood in urine.
Reproductive and breast disorders
Very rareMale infertility, impotence, breast growth (gynecomastia).
General disorders and administration site conditions
Very rareSwelling (edema) of the ankles, general malaise, fatigue, fever.
If you experience any of the following symptoms, stop taking the medication and inform your doctor immediately:
Rare(affects less than 1 in 1,000 people)
Complementary examinations
CommonElevated levels of thyroid-stimulating hormone in the blood.
Cases of fever with or without evident signs or symptoms of generalized hypersensitivity to allopurinol have been reported (see Immune system disorders).
Do not be alarmed by this list of side effects, as it is possible that none of them will occur in your case.
Reporting of adverse reactions
If you experience any type of adverse reaction, consult your doctor or pharmacist, even if it is a possible adverse reaction that does not appear in this prospectus. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use:https://www.notificaRAM.es/. By reporting adverse reactions, you can contribute to providing more information on the safety of this medication.
This medication does not require special storage conditions.
Keep this medication out of the sight and reach of children.
Do not use Zyloric 100 mg tablets after the expiration date that appears on the carton, after “CAD”. The expiration date is the last day of the month indicated.
Do not use Zyloric 100 mg tablets if you observe visible signs of deterioration.
Medicines should not be thrown down the drains or in the trash.Dispose of the packaging and medicines that you no longer need at the SIGRE collection pointof the pharmacy.If in doubt, ask your pharmacist how to dispose of the packaging and medicines that you no longer need. In this way, you will help protect the environment.
Composition of Zyloric 100 mg tablets
Appearance of the product and content of the packaging
Zyloric 100 mg tablets are presented in packs of 25 and 100 tablets.
The tablets are white, round and biconvex.
Holder of the marketing authorization
Faes Farma, S.A.
Autonomia Etorbidea, 10
48940 Leioa(Bizkaia)
Spain
Responsible for manufacturing
Faes Farma, S.A.
Maximo Agirre Kalea, 14
48940 Leioa (Bizkaia)
Spain
Or
Faes Farma, S.A.
Parque Científico y Tecnológico de Bizkaia
Ibaizabal Bidea, Edificio 901
48160 Derio (Bizkaia)
Spain
Last review date of this leaflet: November 2024
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.